about
MicroRNA in Control of Gene Expression: An Overview of Nuclear FunctionsA new method to assay protease based on amyloid misfolding: application to prostate cancer diagnosis using a panel of proteases biomarkersMonitoring the spatiotemporal activities of miRNAs in small animal models using molecular imaging modalities.Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic BiomarkersLong non-coding RNA Malat1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.Mitochondrial miRNA (MitomiR): a new player in cardiovascular health.Stress response factors as hub-regulators of microRNA biogenesis: implication to the diseased heart.Androgen receptor and miR-206 regulation in prostate cancer.Myocardin inhibits estrogen receptor alpha-mediated proliferation of human breast cancer MCF-7 cells via regulating MicroRNA expression.Circulating microRNAs are deregulated in overweight/obese children: preliminary results of the I.Family study.Role of microRNAs in obesity and obesity-related diseases.Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.Influence of middle-distance running on muscular micro RNAs.Muscle-specific microRNA-206 targets multiple components in dystrophic skeletal muscle representing beneficial adaptations.MitomiRs Keep the Heart Beating.MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines
P2860
Q28080201-98DC0821-0FBC-427A-A66F-45CD333A72D1Q30437769-297D1DCF-B95A-4D9D-9DC6-E0C6E5F9C8CCQ35380680-4A0A3642-0FA3-4863-88B1-CF0BDF9337EFQ36204131-001FE793-CDE7-4989-9E38-F2DBFFDBE602Q37437323-19473A3A-F45D-475E-86CD-3E96F9755CB0Q37482775-7DC91C4B-E24C-4F1D-ADA7-1FD82E556681Q38267957-D6796C48-4CF1-40FE-A606-4A81AC99F274Q38510767-8A9CB450-E47D-4769-A305-33296862EDCAQ38667356-810109ED-3304-46D1-9591-BF0B33E00EECQ38946793-177671DB-A452-4791-BAEE-59A13C013AFDQ39785490-962D644F-322C-407C-BB6C-4815E739BB83Q40611472-6DF7CD3D-CD5B-408F-BB8D-0635384C4E86Q41873853-B5505585-B092-4C9F-911D-C52902B1FFD5Q48095155-90C31D6C-5E05-448F-B8CE-A286E445FA1EQ48258655-2DC854FF-1F45-447A-A465-A157BC3F24AFQ51243987-5724223B-6930-448E-88F4-4DEAF930089AQ52768438-9B184C62-C255-4887-9131-2F91CF82C1B7Q58799543-56496756-C433-48F9-B074-9D14D6B0060C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-206: a promising theranostic marker.
@en
MicroRNA-206: a promising theranostic marker.
@nl
type
label
MicroRNA-206: a promising theranostic marker.
@en
MicroRNA-206: a promising theranostic marker.
@nl
prefLabel
MicroRNA-206: a promising theranostic marker.
@en
MicroRNA-206: a promising theranostic marker.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA-206: a promising theranostic marker
@en
P2093
Miroslav Novák
Ondřej Slabý
Peter Kružliak
P2860
P304
P356
10.7150/THNO.7552
P577
2014-01-02T00:00:00Z